MemoryTIDE PLUS forte – benefits in cases of insufficient cerebral blood flow.

Patients and study conditions

Main and control groups

The study on the benefits of the multi-component peptide bioregulator "MemoryTIDE PLUS forte" involved two groups: the main group and the control group.
The main group consisted of 15 patients of different genders, aged 58–87 years, who had been diagnosed with acute cerebrovascular accident.

The control group consisted of 13 patients of similar gender, age, and diagnosis.

Main patient complaints

Patients complained of headaches, increased blood pressure, dizziness, and fatigue.
Older patients were additionally concerned about worsening memory, concentration, and sleep disturbances.

All patients presented with focal neurological symptoms – mild or moderate hemiparesis and/or ataxic syndrome. The duration of the disease ranged from 3 to 8 months.

MemoryTIDE PLUS forte dosage regimen

Dosage and duration of use

During the study, the main group of patients, in addition to standard treatment, were prescribed a 30-60 day course of "MemoryTIDE PLUS forte": 3 capsules per day, depending on the severity of the pathological process.

Research methodology and evaluation criteria

To evaluate the effect of the bioregulator, the following were analyzed before and after treatment:

• patient complaints
• results of routine clinical blood and urine tests,
• blood biochemical parameters
• attention and short-term memory tests.

Results and observed benefits

Improvement in cognitive abilities

It was found that the use of "MemoryTIDE PLUS forte" improved patients' well-being, reduced their main complaints, and strengthened their cognitive abilities.

Results of memory and attention tests.

Short-term memory tests showed that the number of words remembered increased from 4–5 at the beginning of therapy to 6–7 at the end of the course. This is an average of 1.2 words more than in the control group.
Similar results were observed when performing attention assessment tests.

Patients' subjective well-being

The positive disease course was most pronounced in younger patients (58–70 years old). Older patients also showed beneficial dynamics, although they were somewhat weaker.

Safety and absence of side effects

No side effects, complications, or drug dependence were observed throughout the study. None of the patients required discontinuation of the medication.

Conclusions on the benefits of MemoryTIDE PLUS Forte for brain blood circulation.

"MemoryTIDE PLUS forte" may be an important part of complex therapy for patients who have experienced cerebrovascular insufficiency. The study showed that supplemental use of the bioregulator helped improve memory, attention, mood, and overall well-being.

Source of information: https://myrealway.com/memorytide-forte-peptides-for-memory